Filter Results:
(64)
Show Results For
- All HBS Web
(116)
- News (28)
- Research (64)
- Events (1)
- Multimedia (1)
- Faculty Publications (41)
Show Results For
- All HBS Web
(116)
- News (28)
- Research (64)
- Events (1)
- Multimedia (1)
- Faculty Publications (41)
Sort by
- Research Summary
Overview
In examining the competitive dynamics of R&D strategy, Josh has become particularly interested in how the introduction of new knowledge generated by rivals impacts the direction of R&D efforts. Understanding how new information alters project portfolio decisions is... View Details
- 22 Aug 2005
- Research & Ideas
The Hard Work of Failure Analysis
the hospital quickly followed their example, finding the idea compelling and practical. In the pharmaceutical industry, about 90 percent of newly developed drugs fail in the experimental stage, and thus drug... View Details
Keywords: by Amy Edmondson & Mark D. Cannon
- 05 Jul 2006
- Research & Ideas
The Accidental Innovator
Business School, while Devin is professor emeritus from Swarthmore College. Sarah Jane Gilbert: Can you explain what accidental innovation is? What led to your interest in researching this concept? Robert Austin: Historical accounts of many important View Details
Keywords: by Sarah Jane Gilbert
- 15 Nov 2018
- Book
Can the Global Food Industry Overcome Public Distrust?
JamesBrey Food is the largest segment of the global economy. It is also widely recognized as more critical for human health than any pharmaceutical drug on the planet. But significant changes in the industry are making people lose trust in many institutions involved in... View Details
- 25 Apr 2005
- Research & Ideas
New Learning at American Home Products
drug business. They relied, however, on licensing rather than building their own in-house capabilities for drug discovery and commercialization. In the low-tech OTC... View Details
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
Millennium. "With the whole genome known, the process of drug discovery in the future will involve comprehensively identifying all molecular interactions for a drug." Genetic information should be... View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
as 1994: That year was known among insiders as "The Year of the Placebo." What The Data Says The good news: One hundred thirty drugs can be traced to biotech, said Pisano. (For purposes of discussion during his presentation, he... View Details
- 23 Mar 2010
- First Look
First Look: March 23
Publications "From Visible Harm to Relative Risk: Centralization and Fragmentation of Pharmacovigilance Author: Arthur A. Daemmrich Publication: Chap. 13 in The Fragmentation of U.S. Health Care, Oxford University Press, 2010 Abstract Adverse View Details
Keywords: Martha Lagace
- 03 Mar 2009
- First Look
First Look: March 3, 2009
Public Interest: Roche & Tamiflu Harvard Business School Case 609-061 The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu.... View Details
Keywords: Martha Lagace
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace
- 27 Aug 2008
- Research & Ideas
Creating Leaders for Science-Based Businesses
to know how to get those discoveries into the economy." To achieve that goal, Bowen and others believe that science-based companies require a different kind of leadership. "Since the investment and R&D decisions you make... View Details
- 08 Jun 2010
- First Look
First Look: June 8
case:http://cb.hbsp.harvard.edu/cb/product/810123-PDF-ENG Myelin Repair Foundation: Accelerating Drug Discovery Through Collaboration Karim R. Lakhani and Paul R. CarlileHarvard Business School Case 610-074... View Details
Keywords: Martha Lagace
- 20 Nov 2006
- Research & Ideas
Open Source Science: A New Model for Innovation
and perhaps even refine them more. There's a growing movement and establishment of nonprofit foundations that are participating in drug discovery efforts. These foundations aren't as concerned about... View Details
Keywords: by Martha Lagace
- 25 Oct 2016
- First Look
October 25, 2016
insulate consumers from cost sharing, thereby undermining insurers’ ability to influence drug utilization. We study the impact of copay coupons on branded drugs first facing generic entry between 2007 and... View Details
Keywords: Sean Silverthorne
- 02 Jul 2001
- Research & Ideas
Ray A. Goldberg
genome, Goldberg has focused his most recent efforts on explaining the impact of this revolutionary discovery on the agribusiness system. "All industries that deal with living things or organic compounds will have a common language... View Details
- 23 May 2019
- Book
These Entrepreneurs Take a Pragmatic Approach to Solving Social Problems
with multiple myeloma, a rare and incurable blood cancer, Kathy Giusti cofounded the Multiple Myeloma Research Foundation, which has helped thousands of other patients with the cancer and has accelerated drug View Details
- 03 Apr 2007
- First Look
First Look: April 3, 2007
drug discovery organization at Wyeth Pharmaceuticals and focuses on the decisions to: (1) centralize decision-making within drug discovery and... View Details
Keywords: Martha Lagace
- 18 Jun 2001
- Research & Ideas
When In-House Research Isn’t Enough
to intellectual property, it's clear they realize they don't have to own a discovery to profit from it," Chesbrough remarked. Years ago, Xerox's legendary Palo Alto Research Center (PARC) was the source of such major advances as the... View Details
Keywords: by Jim Aisner
- 01 May 2007
- First Look
First Look: May 1, 2007
countries. Download working paper: http://www.hbs.edu/research/pdf/07-073.pdf Open vs. Integrated Innovation: A Model of Discovery and Confinement Authors:Esteve Almirall and Ramon Casadesus-Masanell Abstract We present a simple formal... View Details
Keywords: Sean Silverthorne
- 04 Feb 2014
- First Look
First Look: February 4
process of moving new therapies from discovery to patients in need. Although the annual conference (Partnering for Cures) to improve how government research was organized was a huge success, Anderson considered refocusing resources on... View Details
Keywords: Sean Silverthlorne